Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E4WF
|
||||
Former ID |
DNC003856
|
||||
Drug Name |
METHYLTHIOADENOSINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Multiple scierosis [ICD9: 340; ICD10:G35] | Terminated | [544778] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H15N5O3S
|
||||
Canonical SMILES |
CSCC1C(C(C(O1)N2C=NC3=C2N=CN=C3N)O)O
|
||||
InChI |
1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1
|
||||
InChIKey |
WUUGFSXJNOTRMR-IOSLPCCCSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [527040] | |
Adenosine A2a receptor | Target Info | Inhibitor | [527040] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [527040] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [527040] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.